Th2 cytokine response in Major Depressive Disorder patients before treatment

Area of Science:

• Neuroimmunology
• Psychiatry
• Endocrinology

Background:

• Major Depressive Disorder (MDD) is associated with dysregulated neuroendocrine-immune interactions.
• Understanding the pro-inflammatory (Th1) and anti-inflammatory (Th2) cytokine balance is crucial in MDD pathogenesis.

Purpose of the Study:

• To investigate the Th1/Th2 cytokine balance in MDD patients compared to controls.
• To explore the relationship between immune markers, cortisol levels, and MDD.

Main Methods:

• Comparative analysis of cytokine levels (IL-2, IFN-gamma, IL-4, IL-13) in MDD patients and healthy controls.
• Flow cytometry to assess immune cell populations (CD3+CD8+, NK, B cells, CD3+CD4+ lymphocytes).
• Measurement of serum cortisol and TNF-alpha levels.

Main Results:

• MDD subjects had elevated cortisol and TNF-alpha.
• Increased percentages of CD3+CD8+ and NK cells, with diminished B cell counts observed in MDD.
• A shift towards Th2 dominance was noted, with higher IL-4/IL-13 and lower IL-2/IFN-gamma levels in MDD patients.

Conclusions:

• MDD is characterized by significant alterations in immune cell populations and cytokine profiles.
• Elevated cortisol levels may be linked to the observed immune dysregulation in MDD.
• These findings suggest novel therapeutic avenues targeting the neuroimmune axis in MDD.